Skip to main content
. 2023 Jan 10;24(2):1347. doi: 10.3390/ijms24021347
αIL-17A anti-Interleukin-17A antibody
A1C Hemoglobin glycated average blood sugar
ANOVA Analysis of variance
Act1 adaptor molecule 1
BCA Bicinchoninic acid
BW Body weight
CU Chemiluminescent unit
DB Diabetic
db/db Leprdb mice
ELISA Enzyme-linked immunosorbent assay
ERK5 Extracellular signal receptor kinase 5
FADD Fas-associated death domain
FBG Fasted blood glucose
FDA Food and drug administration
Het Heterozygous
IgG1 Immunoglobulin G1
IL-1β Interleukin-1 beta
IL-6 Interleukin-6
IL-17A Interleukin-17A
IL17R Interleukin-17A receptor
IL-17RA Interleukin-17A receptor A
IP Intraperitoneal
kDa Kilo-Dalton
MW Molecular weight
ND Non-diabetic
NFκB Nuclear factor kappa B
RORγt Retinoic acid-related orphan receptor-gamma t
SD Standard deviation
SEM Standard error of the mean
STZ Streptozotocin
Th17 T helper 17
TNF-α Tumor necrosis factor alpha
TRAF TNF receptor associated factor
TRAF6 TNF receptor associated factor 6
VEGF Vascular endothelial growth factor
ZO-1 Zonula occludens-1